๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial

โœ Scribed by Vittorio Ferrari; Francesca Valcamonico; Vito Amoroso; Edda Simoncini; Lucia Vassalli; Patrizia Marpicati; Giovanni Rangoni; Salvatore Grisanti; Guido AM Tiberio; Franco Nodari; Carla Strina; Giovanni Marini

Publisher
Springer
Year
2005
Tongue
English
Weight
200 KB
Volume
57
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A pharmacological study of celecoxib and
A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer
โœ Henry Q. Xiong; William Plunkett; Robert Wolff; Min Du; Renato Lenzi; James L. A ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› Springer ๐ŸŒ English โš– 223 KB

## Purpose: To evaluate whether celecoxib alters the conversion of gemcitabine into its active metabolite, difluorodeoxycytidine triphosphate (dfdctp), in peripheral blood mononuclear cells (pbmcs). ## Methods: Patients with advanced pancreatic cancer who had not received chemotherapy and had acc